Atossa Therapeutics's total assets for Q1 2025 were $70.75M, a decrease of -7.45% from the previous quarter. ATOS total liabilities were $5.42M for the fiscal quarter, a 9.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.